- Home
- QNCX vs TBI Comparison
QNCX vs TBI Comparison
Compare QNCX & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNCX | TBI |
|---|---|---|
| Founded | 2012 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 139.9M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | QNCX | TBI |
|---|---|---|
| Price | $3.06 | $5.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $7.67 | $6.00 |
| AVG Volume (30 Days) | ★ 979.1K | 180.2K |
| Earning Date | 11-12-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,583,772,000.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | N/A | $5.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $3.45 |
| 52 Week High | $4.55 | $8.55 |
Technical Indicators
Market Signals| Indicator | QNCX | TBI |
|---|---|---|
| Relative Strength Index (RSI) | 47.31 | 61.39 |
| Support Level | $2.85 | $4.92 |
| Resistance Level | $3.72 | $5.34 |
| Average True Range (ATR) | 0.31 | 0.28 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 41.38 | 80.82 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.